AU Patent

AU2002256967A1 — Treating or reducing the risk of cardiovascular disease

Assigned to Merck Sharp and Dohme LLC · Expires 2002-09-12 · 24y expired

What this patent protects

Patent listed against cetirizine-hydrochloride.

Drugs covered by this patent

cetirizine-hydrochloride (CETIRIZINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2002256967A1
Jurisdiction: AU
Classification: —
Expires: 2002-09-12
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.